| Bangkok workshop on leprosy research: treatment of reactions and nerve damage B Naafs International Journal of Leprosy and Other Mycobacterial Diseases 64 (4), S21, 1996 | 118 | 1996 |
| Leprosy reactions. New knowledge. B Naafs Tropical and geographical medicine 46 (2), 80-84, 1994 | 118 | 1994 |
| Position statement: LEPROSY: Diagnosis, treatment and follow‐up W Alemu Belachew, B Naafs Journal of the European Academy of Dermatology and Venereology 33 (7), 1205-1213, 2019 | 102 | 2019 |
| Thalidomide therapy: an open trial B Naafs, WR Faber International journal of dermatology 24 (2), 131-134, 1985 | 92 | 1985 |
| Thalidomide treatment of subacute cutaneous lupus erythematosus B Naafs, EJM Barkers, J Flinterman, WR Fabbr British Journal of Dermatology 107 (1), 83-86, 1982 | 73 | 1982 |
| Sensory testing: a sensitive method in the follow-up of nerve involvement B Naafs, T Dagne Int J Lepr 45 (4), 364-368, 1977 | 71 | 1977 |
| Reversal reaction: the prevention of permanent nerve damage. Comparison of short and long-term steroid treatment B Naafs, JMH Pearson, HW Wheate Int J Lepr Other Mycobact Dis 47 (1), 7-12, 1979 | 66 | 1979 |
| Current views on reactions in leprosy. B Naafs Indian journal of leprosy 72 (1), 97-122, 2000 | 65 | 2000 |
| Leprosy type 1 reaction (formerly reversal reaction) B Naafs, CLM van Hees Clinics in Dermatology 34 (1), 37-50, 2016 | 60 | 2016 |
| Treatment of leprosy: science or politics? B Naafs Tropical Medicine & International Health 11 (3), 268-278, 2006 | 59 | 2006 |
| Leprosy and HIV coinfection: a critical approach C Massone, C Talhari, R Ribeiro-Rodrigues, RHM Sindeaux, MT Mira, ... Expert Review of Anti-Infective Therapy 9 (6), 701-710, 2011 | 53 | 2011 |
| The time interval between the start of anti-leprosy treatment and the development of reactions in borderline patients B Naafs, HW Wheate Lepr Rev 49 (2), 153-7, 1978 | 51 | 1978 |
| Case report: Leprosy and tuberculosis co-infection: clinical and immunological report of two cases and review of the literature MÂB Trindade, D Miyamoto, G Benard, NY Sakai-Valente, ... The American journal of tropical medicine and hygiene 88 (2), 236, 2013 | 46 | 2013 |
| Enhancing Sensitivity of Detection of Immune Responses to Mycobacterium leprae Peptides in Whole-Blood Assays A Geluk, JJ van der Ploeg-van Schip, KE Van Meijgaarden, ... Clinical and Vaccine Immunology 17 (6), 993-1004, 2010 | 46 | 2010 |
| Leprosy and HIV co-infection in five patients MAB Trindade, MP Manini, JH Masetti, MA Leite, MDF Takahashi, B Naafs Leprosy review 76 (2), 162-166, 2005 | 45 | 2005 |
| Diagnostic problems with imported cases of mycetoma in The Netherlands: Schwierigkeiten in der Diagnostik importierter Myzetome in den Niederlanden GS De Hoog, A Buiting, CS Tan, AB Stroebel, C Ketterings, EJ De Boer, ... Mycoses 36 (3‐4), 81-87, 1993 | 42 | 1993 |
| Reactions in leprosy B Naafs, S Noto Leprosy and Buruli Ulcer: A Practical Guide, 233-258, 2022 | 41 | 2022 |
| Quality of life of patients with vitiligo attending the Regional Dermatology Training Center in Northern Tanzania S Kiprono, B Chaula, C Makwaya, B Naafs, J Masenga International journal of dermatology 52 (2), 191-194, 2013 | 40 | 2013 |
| Anti-Mycobacterium leprae monoclonal antibodies cross-react with human skin: an alternative explanation for the immune responses in leprosy B Naafs, AHJ Kolk, RAMCA Lien, WR Faber, G Van Dijk, S Kuijper, ... Journal of investigative dermatology 94 (5), 685-688, 1990 | 38 | 1990 |
| Diabetes mellitus associated with pentamidine mesyiate. A Belehu, B Naafs Diabetes mellitus associated with pentamidine mesyiate. 1, 1463-1464, 1982 | 38 | 1982 |
